141 related articles for article (PubMed ID: 15561271)
1. Allogeneic T-cell apoptosis induced by interleukin-10-modified dendritic cells: a mechanism of prolongation of intestine allograft survival?
Zhu M; Wei MF; Liu F; Shi HF; Wang G; Chen S
Transplant Proc; 2004 Oct; 36(8):2436-7. PubMed ID: 15561271
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival.
Zhu M; Wei MF; Liu F; Shi HF; Wang G
World J Gastroenterol; 2003 Nov; 9(11):2509-12. PubMed ID: 14606086
[TBL] [Abstract][Full Text] [Related]
3. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
[TBL] [Abstract][Full Text] [Related]
4. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
[TBL] [Abstract][Full Text] [Related]
5. Immature rat myeloid dendritic cells generated in low-dose granulocyte macrophage-colony stimulating factor prolong donor-specific rat cardiac allograft survival.
DePaz HA; Oluwole OO; Adeyeri AO; Witkowski P; Jin MX; Hardy MA; Oluwole SF
Transplantation; 2003 Feb; 75(4):521-8. PubMed ID: 12605121
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness.
Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M
Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice.
Dai H; Zhu H; Lei P; Yagita H; Liu J; Wen X; Zhou W; Gong F; Shen G; Fang M
Transplantation; 2009 Oct; 88(7):864-73. PubMed ID: 19935456
[TBL] [Abstract][Full Text] [Related]
9. Induction of donor-specific T-cell hyporesponsiveness using dexamethasone-treated dendritic cells in two fully mismatched rat kidney transplantation models.
Stax AM; Gelderman KA; Schlagwein N; Essers MC; Kamerling SW; Woltman AM; van Kooten C
Transplantation; 2008 Nov; 86(9):1275-82. PubMed ID: 19005410
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of rat intestinal allograft survival by administration of triptolide-modified donor bone marrow-derived dendritic cells.
Chen T; Xu H; Wang HQ; Zhao Y; Zhu CF; Zhang YH; Ji MJ; Hua YB; Wu WX
Transplant Proc; 2008 Dec; 40(10):3711-3. PubMed ID: 19100471
[TBL] [Abstract][Full Text] [Related]
11. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
[TBL] [Abstract][Full Text] [Related]
13. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
14. Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells.
Roelen DL; Schuurhuis DH; van den Boogaardt DE; Koekkoek K; van Miert PP; van Schip JJ; Laban S; Rea D; Melief CJ; Offringa R; Ossendorp F; Claas FH
Transplantation; 2003 Dec; 76(11):1608-15. PubMed ID: 14702533
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.
Sun W; Wang Q; Zhang L; Pan J; Zhang M; Lu G; Yao H; Wang J; Cao X
J Mol Med (Berl); 2002 Aug; 80(8):514-23. PubMed ID: 12185452
[TBL] [Abstract][Full Text] [Related]
16. Combination treatment with donor interleukin-12p35 silenced dendritic cells and cyclosporine induces long-term survival of intestinal allografts in rats.
Xu H; Chen T; Wang HQ; Hua YB; Wu WW
Transplant Proc; 2007; 39(1):286-8. PubMed ID: 17275524
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell transfected with secondary lymphoid-tissue chemokine and/or interleukin-2 gene-enhanced cytotoxicity of T-lymphocyte in human bladder tumor cell S in vitro.
Li YG; Wang ZP; Tian JQ; Tian BQ; Rodrigues R; Shang PF; Zhang T
Cancer Invest; 2009 Nov; 27(9):909-17. PubMed ID: 19832038
[TBL] [Abstract][Full Text] [Related]
18. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
19. Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
Tiao MM; Lu L; Tao R; Harnaha J; Fung JJ; Huang LT; Qian S
Transplant Proc; 2004 Jun; 36(5):1592-4. PubMed ID: 15251391
[TBL] [Abstract][Full Text] [Related]
20. Improvement of heart allograft acceptability associated with recruitment of CD4+CD25+ T cells in peripheral blood by recipient treatment with granulocyte colony-stimulating factor.
Liang HL; Yi DH; Zheng QJ; Du JF; Cao YX; Yu SQ; Zhu HL
Transplant Proc; 2008 Jun; 40(5):1604-11. PubMed ID: 18589159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]